Morgan Stanley raised the firm’s price target on Lumentum (LITE) to $350 from $304 and keeps an Equal Weight rating on the shares. Into fiscal Q2 EPS, the biggest unknowns are largely on margins, as demand conditions remain strong and the company remains largely capacity constrained, the analyst tells investors in a preview.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LITE:
